Not Yet Recruiting
SKB264 Combined With KL-A167 Neoadjuvant Therapy for Early-stage, High-risk ER+/HER2- Breast Cancer
NCT07109284
- Conditions
- ER+HER2- Breast Cancer
- Locations
-
Not specified